| Primary cohort | Validation cohort |
---|---|---|
General characteristics | Â | Â |
   Age | β = 0.02, P = 0.79 | β = 0.03, P = 0.73 |
   Gender | 0.97 (0.96 to 0.99)* | 0.98 (0.96 to 0.99)* |
Disease-related characteristics | Â | Â |
   Log disease duration | β = 0.21, p = 0.01 | β = 0.12, P = 0.21 |
   RF positivity | 0.90 (0.99 to 1.02) | n/a |
   Log ESR | β = - 0.20, P = 0.01 | β= -0.144, P = 0.131 |
   Log CRP | β = - 0.23, P = 0.003 | β = - 0.28, P = 0.002 |
   DAS28 | β = -0.12, P = 0.09 | n/a |
   HAQ | β = -0.11, P = 0.16 | n/a |
Classical CVD risk factors | Â | Â |
   Body mass index | β = - 0.13, P = 0.05 | β = - 0.19, P = 0.18 |
   Pulse pressure | β = - 0.23, P = 0.004 | β = - 0.21, P = 0.017 |
   Mean blood pressure | β = -0.10, P = 0.15 | β = -0.17, P = 0.05 |
   Heart rate | β = -0.64, P < 0.001 | β = - 0.76 P < 0.001 |
   Total cholesterol | β = -0.12, P = 0.09 | β = -0.14, P = 0.14 |
   TC:HDL ratio | β = -0.02, P = 0.76 | β = -0.09, P = 0.35 |
   Triglycerides | β = -0.01, P = 0.90 | β = 0.01, P = 0.94 |